Skip to content
Her Choice

The Latest on Medication Abortion Access: The Court Awaits the FDA Review

Despite for calls from Republican leaders and anti-abortion organizations for the FDA to act quickly, the Louisiana district court has given the FDA until October 7, 2026, one month before the midterms, to file a report with the status of its review and any updated timeframe for completion.

The Latest on Medication Abortion Access: The Court Awaits the FDA Review

Need Support?

Find verified resources for reproductive healthcare, support services, and advocacy organizations.

Find Resources